SCNI
Scinai Immunotherapeutics Ltd
NASDAQ: SCNI · HEALTHCARE · BIOTECHNOLOGY
$0.74
+3.67% today
Updated 2026-04-30
Market cap
$2.06M
P/E ratio
0.00
P/S ratio
1.58x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$0 – $3
Volume
4.1M
Scinai Immunotherapeutics Ltd (SCNI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.35M | $1.98M | $592000.00 | $3.20M | $8.95M | $8.68M | $7.16M | $6.22M | $7.45M | $4.74M | $10.60M | $7.82M | $23.48M | $28.30M | $33.52M | $17.71M | $32.04M | $27.07M | $17.47M | $13.45M |
| Cash & equivalents | $1.17M | $688000.00 | $5000.00 | $55070.00 | $230728.00 | $576317.00 | $367697.00 | $2.55M | $5.15M | $2.47M | $8.59M | $4.08M | $20.51M | $20.29M | $20.98M | $2.93M | $17.37M | $14.07M | $4.87M | $1.96M |
| Current assets | — | — | — | $2.99M | $8.21M | $7.37M | $5.40M | $4.50M | $5.87M | $3.26M | $9.48M | $6.78M | $21.64M | $20.55M | $21.17M | $3.31M | $17.84M | $14.37M | $5.45M | $2.39M |
| Total liabilities | $643000.00 | $240000.00 | $3.91M | $197776.00 | $512671.00 | $742068.00 | $450860.00 | $272576.00 | $529761.00 | $481226.00 | $1.99M | $1.17M | $7.31M | $36.65M | $52.36M | $22.25M | $31.05M | $28.83M | $22.04M | $3.47M |
| Current liabilities | $643000.00 | $240000.00 | $3.61M | $192216.00 | $505279.00 | $732185.00 | $439876.00 | $259711.00 | $513900.00 | $465313.00 | $436032.00 | $356883.00 | $1.98M | $5.83M | $5.49M | $19.97M | $2.44M | $2.34M | $1.78M | $1.81M |
| Long-term debt | — | — | $300000.00 | — | — | — | — | — | — | — | — | — | — | — | $123.78M | — | $63.25M | $20.08M | $19.37M | $260000.00 |
| Shareholder equity | $2.70M | $1.74M | — | $3.00M | $8.44M | $7.94M | $6.71M | $5.95M | $6.92M | $4.26M | $8.61M | $6.65M | $16.17M | $-8.35M | $-18.84M | $-4.54M | $982000.00 | $-1.76M | $-4.57M | $9.98M |
| Retained earnings | — | — | — | $-6.03M | $-7.22M | $-10.34M | $-11.60M | $-14.39M | $-17.80M | $-17.83M | $-20.45M | $-23.07M | $-35.47M | $-56.46M | $-92.76M | $-101.05M | $-110.04M | $-115.83M | $-122.33M | $-117.54M |
| Accounts receivable | — | — | — | $43950.00 | $60718.00 | $114077.00 | $183587.00 | $455902.00 | $461000.00 | $1.04M | $1.40M | $764000.00 | $3.17M | $256226.00 | $349000.00 | $71216.00 | $325151.00 | $110000.00 | $330000.00 | $217000.00 |
| Inventory | $1.62M | $796000.00 | $218000.00 | $1.00 | $2.00 | $0.00 | — | — | — | — | — | $51000.00 | — | — | — | $-3.87M | $-240848.00 | $-852279.00 | $-366000.00 | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |